A UK-based service provider, BioSilta Ltd, has raised €2.5 million from its founding investor and the new investor Omega Funds in order to support the commercial expansion of its reagent-based growth systems for bacterial cultures. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
